专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明公开

KR1020120035404A 열경화성 에폭시 수지용 열 잠재성 경화제 및 그 제조방법, 이를 포함하는 에폭시 수지 조성물 有权
标题翻译：用于环氧树脂的热固性催化剂及其制备，包含该环氧树脂的环氧树脂化合物
公开(公告)号：KR1020120035404A
公开(公告)日：2012-04-16
申请号：KR1020100096897
申请日：2010-10-05
申请人： 연세대학교 산학협력단
发明人： 한학수 , 장의성 , 남윤희 , 최봉구
IPC分类号： C08K5/3472 , C08G59/40 , C07D233/12 , C08L63/00
CPC分类号： C08K5/3445 , C07D233/12 , C08G59/4014 , C08K3/16 , C08L63/00
摘要： PURPOSE: A heat-latent hardener is provided to have excellent storage stability, and low temperature fast curing quickly, and to obtain an epoxy resin composition with thermal resistance, water resistance, and weather resistance. CONSTITUTION: A heat-latent hardener comprises for a heat curable epoxy resin is in chemical formula 1. In chemical formula 1, R is C1-5 alkylene, and X is hydrogen and phenyl group. A manufacturing method of the heat-latent hardener comprises: a step of mixing methylimidazolium and acetonitrile; a step of obtaining butyl methylimidazolium by reacting the mixture with chlorobutane; and a step of dissolving the butyl methylimidazolium and hexafluloroantimonate into distilled water, and polymerizing by mixing obtained solutions.
摘要翻译：目的：提供一种热潜硬化剂以具有优异的储存稳定性和快速快速固化的低温，并获得具有耐热性，耐水性和耐候性的环氧树脂组合物。构成：热可溶性固化剂包括化学式1中的热固化环氧树脂。在化学式1中，R为C 1-5亚烷基，X为氢和苯基。热潜硬化剂的制造方法包括：将甲基咪唑和乙腈混合的工序; 通过使混合物与氯丁烷反应获得丁基甲基咪唑的步骤; 以及将丁基甲基咪唑鎓和六氟锑酸盐溶解在蒸馏水中的步骤，并通过混合获得的溶液进行聚合。

2. 发明公开

KR1020140013802A 이온성 액체 ＥＭＩ-ＢＦ₄의 정제방법 无效
标题翻译：用于离子液体的净化方法EMI-BF_4
公开(公告)号：KR1020140013802A
公开(公告)日：2014-02-05
申请号：KR1020120082351
申请日：2012-07-27
申请人： 캡솔루션 주식회사
发明人： 이영환 , 전경수 , 양경철 , 김형찬 , 정경식 , 이광제
IPC分类号： C07F5/02 , C07D233/12 , B01D3/14
CPC分类号： C07D233/12 , B01D3/14
摘要： The present invention relates to a purifying method for high purity ionic liquid 1-ethyl-3-methylimidazolium tetrafluoroborate (EMI-BF4) comprising: a step of preparing synthesized EMI-BF4 (1-ethyl-3-methylimidazolium tetrafluoroborate); a step of removing precipitates existing in the synthesized EMI-BF4 by passing the synthesized EMI-BF4 through a glass filter; a step of performing primary vacuum distillation on the EMI-BF4 in which precipitates are removed; a step of mixing a distilled water mixture and the EMI-BF4 in a predetermined ratio and extracting ionic liquids with a liquid/liquid continuous extraction process by an extraction solvent; a step of drying the extracted ionic liquid by removing moisture; and a step of performing secondary vacuum distillation on the dried EMI-BF4. [Reference numerals] (AA) Filtration; (BB) Vacuum distillation (100mmHg ↓ 24hr, 10mmHg ↓ 24hr); (CC) Mixing with a distilled water in a predetermined ratio; (DD) Extracting for 48 hours by an extraction solvent (dichloromethane); (EE) Drying (MgSO_4 anhydrous) vacuum distillation (100mmHg ↓ 24hr, 1mmHg ↓ 48hr); (FF) High purity ionic liquid (Purified 1-ethyl-3-methylimidazolium tetrafluoroborate)
摘要翻译：本发明涉及一种高纯度离子液体1-乙基-3-甲基咪唑鎓四氟硼酸盐（EMI-BF4）的净化方法，包括：制备合成的EMI-BF4（1-乙基-3-甲基咪唑鎓四氟硼酸盐）的步骤; 通过将合成的EMI-BF 4通过玻璃过滤器去除合成的EMI-BF4中存在的沉淀物的步骤; 在去除了析出物的EMI-BF4上进行一次真空蒸馏的步骤; 以预定比例混合蒸馏水混合物和EMI-BF4并通过萃取溶剂用液/液连续萃取方法提取离子液体的步骤; 通过去除水分干燥所提取的离子液体的步骤; 以及在干燥的EMI-BF 4上进行二次真空蒸馏的步骤。（标号）（AA）过滤; （BB）真空蒸馏（100mmHg↓24hr，10mmHg↓24hr）; （CC）以预定比例与蒸馏水混合; （DD）通过萃取溶剂（二氯甲烷）萃取48小时; （EE）干燥（无水MgSO 4）减压蒸馏（100mmHg↓24hr，1mmHg↓48hr）; （FF）高纯度离子液体（纯化的1-乙基-3-甲基咪唑鎓四氟硼酸盐）

3. 发明公开

KR1020140008235A 전자 주입 능력 및/또는 전자 수송 능력을 가지는 신규한 화합물 및 이를 포함한 유기 발광 소자 审中-实审
标题翻译：具有电子注入能力和/或电子传输能力的新型化合物和包含其的有机发光装置
公开(公告)号：KR1020140008235A
公开(公告)日：2014-01-21
申请号：KR1020130016979
申请日：2013-02-18
申请人： 삼성디스플레이 주식회사
发明人： 정혜진 , 황석환 , 김영국 , 임진오 , 한상현 , 정은재 , 김수연 , 박준하 , 이은영 , 이창호 , 이종혁
IPC分类号： C09K11/06 , C07D233/12 , C07D401/04 , H01L51/50
CPC分类号： H01L51/0072 , C07D233/12 , C07D401/04 , H01L27/3274 , H01L51/0067 , H01L51/0069 , H01L51/5072 , H01L51/5092
摘要： Disclosed is a compound of formula 1 and an organic light emitting device including the same. The information on formula 1 refers to detailed description. [Reference numerals] (AA) Second electrode; (BB) Electron injection layer; (CC) Electron transfer layer; (DD) Light emitting layer; (EE) Hole transfer layer; (FF) Hole injection layer; (GG) First electrode
摘要翻译：公开了式1的化合物和包含该化合物的有机发光器件。关于公式1的信息是指详细描述。（附图标记）（AA）第二电极; （BB）电子注入层; （CC）电子转移层; （DD）发光层; （EE）空穴转移层; （FF）空穴注入层; （GG）第一电极

4. 发明公开

KR1020100029145A 4-이미다졸린 및 항우울제로서 이의 용도 失效
标题翻译： 4-咪唑啉及其作为抗生素的用途
公开(公告)号：KR1020100029145A
公开(公告)日：2010-03-15
申请号：KR1020107002417
申请日：2008-06-24
申请人： 에프. 호프만-라 로슈 아게
发明人： 갈레이구이도 , 그로에브케쯔빈덴카트린 , 노르크로스로저 , 스탈더헨리
IPC分类号： C07D233/24 , C07D233/12 , A61K31/4174 , A61P25/24
CPC分类号： C07D233/06 , C07D233/12 , C07D233/22 , C07D233/24
摘要： The present invention relates to compounds of formula (I) wherein Ris hydrogen, halogen or lower alkyl; Ris hydrogen or amino; X-Y is-(CH)-, N(R)-CH-,-O-CH-or-S-CH-; Ar is phenyl or naphthyl; n is 1 or 2; R is hydrogen or lower alkyl; and to their pharmaceutically active salts, with the exclusion of the racemic compound 4-benzyl-4,5-dihydro-lH-imidazole or its tautomer (CAS 131548-83-9). It has been found that the compounds of formula (I) have a good affinity to the trace amine associated receptors (TAARs), especially for TAAR1. The compounds may be used for the treatment of depression, anxiety disorders, bipolar disorder, attention deficit hyperactivity disorder (ADHD), stress-related disorders, psychotic disorders such as schizophrenia, neurological diseases such as Parkinson's disease, neurodegenerative disorders such as Alzheimer's disease, epilepsy, migraine, hypertension, substance abuse and metabolic disorders such as eating disorders, diabetes, diabetic complications, obesity, dyslipidemia, disorders of energy consumption and assimilation, disorders and malfunction of body temperature homeostasis, disorders of sleep and circadian rhythm, and cardiovascular disorders.
摘要翻译：本发明涉及式（I）的化合物，其中R 1为氢，卤素或低级烷基; Ris是氢或氨基; X-Y是 - （CH） - ，N（R）-CH - ， - O-CH-或-S-CH-; Ar是苯基或萘基; n为1或2; R是氢或低级烷基; 和其药物活性盐，排除外消旋化合物4-苄基-4,5-二氢-1H-咪唑或其互变异构体（CAS 131548-83-9）。已经发现式（I）化合物对微量胺相关受体（TAAR）具有良好的亲和力，特别是对于TAAR1。这些化合物可用于治疗抑郁症，焦虑障碍，双相情感障碍，注意力缺陷多动障碍（ADHD），应激相关疾病，精神病性精神障碍如精神分裂症，神经系统疾病如帕金森病，神经变性疾病如阿尔茨海默病，癫痫，偏头痛，高血压，药物滥用和代谢障碍如进食障碍，糖尿病，糖尿病并发症，肥胖症，血脂异常，能量消耗和同化障碍，体温平衡紊乱和失调，睡眠和昼夜节律紊乱以及心血管疾病。

5. 发明公开

KR1020090092322A 칸나비노이드 수용체 1 활성의 억제제로서 화합물 및 조성물 失效
标题翻译：化合物和组合物作为CANNABINOID受体1活性的抑制剂
公开(公告)号：KR1020090092322A
公开(公告)日：2009-08-31
申请号：KR1020097014668
申请日：2007-12-12
申请人： 아이알엠 엘엘씨
发明人： 리우,홍 , 헤,시아오후이 , 필립스,딘 , 주,쉬에펭 , 양,군용 , 라우,토마스 , 우,바오젠 , 셰,융핑 , 엔구엔,트룩응옥 , 왕,씽
IPC分类号： C07D413/04 , C07D403/06 , C07D285/06 , C07D233/50
CPC分类号： C07D265/32 , C07D207/26 , C07D207/40 , C07D233/12 , C07D233/16 , C07D233/32 , C07D233/38 , C07D233/42 , C07D233/46 , C07D233/50 , C07D233/52 , C07D233/74 , C07D263/20 , C07D263/22 , C07D285/06 , C07D403/04 , C07D403/06 , C07D403/14 , C07D413/04 , C07D413/06 , C07D413/12 , C07D413/14 , C07F7/1856
摘要： The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of Cannabinoid Receptor 1 (CB1). ® KIPO & WIPO 2009
摘要翻译：本发明提供化合物，包含这些化合物的药物组合物和使用这些化合物治疗或预防与大麻素受体1（CB1）的活性相关的疾病或病症的方法。 ®KIPO＆WIPO 2009

6. 发明公开

KR1020140018485A 짝이온성 탄소나노튜브, 및 짝이온성 탄소나노튜브-금속 나노입자의 복합체 有权
标题翻译：中性碳纳米管和中性碳纳米管 - 金属纳米颗粒的复合材料
公开(公告)号：KR1020140018485A
公开(公告)日：2014-02-13
申请号：KR1020120084311
申请日：2012-08-01
申请人： 이화여자대학교 산학협력단
发明人： 이상기 , 이종목 , 신주연 , 김연수 , 차아름
IPC分类号： B82B1/00 , B82B3/00 , C07D233/12 , C01B31/02
CPC分类号： C01B32/168 , B82B1/00 , B82B3/0009 , C01B2202/02 , C01B2202/06 , C07D233/12
摘要： The present invention relates to a zwitterionic carbon nanotube, a composite of zwitterionic carbon nanotube-metallic nanoparticle, a manufacturing method of a zwitterionic carbon nanotube and a composite of zwitterionic carbon nanotube-metallic nanoparticle, and a fuel cell including, as a cathode catalyst, a zwitterionic carbon nanotube and a composite of zwitterionic carbon nanotube-metallic nanoparticle.
摘要翻译：本发明涉及两性离子碳纳米管，两性离子碳纳米管 - 金属纳米颗粒的复合物，两性离子碳纳米管的制造方法和两性离子性碳纳米管 - 金属纳米粒子的复合体，以及包含作为阴极催化剂的燃料电池，两性离子碳纳米管和两性离子碳纳米管金属纳米粒子的复合材料。

7. 发明授权

KR101150628B1 4-이미다졸린 및 항우울제로서 이의 용도 失效
标题翻译： 4-咪唑啉及其作为抗生素的用途
公开(公告)号：KR101150628B1
公开(公告)日：2012-05-31
申请号：KR1020107002417
申请日：2008-06-24
申请人： 에프. 호프만-라 로슈 아게
发明人： 갈레이구이도 , 그로에브케쯔빈덴카트린 , 노르크로스로저 , 스탈더헨리
IPC分类号： C07D233/24 , C07D233/12 , A61K31/4174 , A61P25/24
CPC分类号： C07D233/06 , C07D233/12 , C07D233/22 , C07D233/24
摘要： The present invention relates to compounds of formula wherein R1, R2, X, Y and Ar are as defined herein and to their pharmaceutically active salts, with the exclusion of the racemic compound 4-benzyl-4,5-dihydro-1H-imidazole or its tautomer (CAS 131548-83-9). Compounds of formula I have a good affinity to the trace amine associated receptors (TAARs), especially for TAAR1 and are useful for the treatment of depression, anxiety disorders, bipolar disorder, attention deficit hyperactivity disorder (ADHD), stress-related disorders, psychotic disorders such as schizophrenia, neurological diseases such as Parkinson's disease, neurodegenerative disorders such as Alzheimer's disease, epilepsy, migraine, hypertension, substance abuse and metabolic disorders such as eating disorders, diabetes, diabetic complications, obesity, dyslipidemia, disorders of energy consumption and assimilation, disorders and malfunction of body temperature homeostasis, disorders of sleep and circadian rhythm, and cardiovascular disorders.

8. 发明授权

KR101245918B1 칸나비노이드 수용체 1 활성의 억제제로서 화합물 및 조성물 失效
标题翻译：化合物和组合物作为CANNABINOID受体1活性的抑制剂
公开(公告)号：KR101245918B1
公开(公告)日：2013-03-20
申请号：KR1020097014668
申请日：2007-12-12
申请人： 아이알엠 엘엘씨
发明人： 리우,홍 , 헤,시아오후이 , 필립스,딘 , 주,쉬에펭 , 양,군용 , 라우,토마스 , 우,바오젠 , 셰,융핑 , 엔구엔,트룩응옥 , 왕,씽
IPC分类号： C07D413/04 , C07D403/06 , C07D285/06 , C07D233/50
CPC分类号： C07D265/32 , C07D207/26 , C07D207/40 , C07D233/12 , C07D233/16 , C07D233/32 , C07D233/38 , C07D233/42 , C07D233/46 , C07D233/50 , C07D233/52 , C07D233/74 , C07D263/20 , C07D263/22 , C07D285/06 , C07D403/04 , C07D403/06 , C07D403/14 , C07D413/04 , C07D413/06 , C07D413/12 , C07D413/14 , C07F7/1856
摘要： 본 발명은 칸나비노이드 수용체 1 (CB1)의 활성과 관련된 질환 또는 장애를 치료 또는 예방하기 위한 화합물, 상기 화합물을 포함하는 제약 조성물, 및 상기 화합물을 사용하여 상기 질환 또는 장애를 치료 또는 예방하는 방법을 제공한다.
칸나비노이드 수용체 1 (CB1), 섭식 장애, 비만

9. 发明公开

KR1020120054106A 칸나비노이드 수용체 1 활성의 억제제로서 화합물 및 조성물 无效
标题翻译：化合物和组合物作为CANNABINOID受体1活性的抑制剂
公开(公告)号：KR1020120054106A
公开(公告)日：2012-05-29
申请号：KR1020127011377
申请日：2007-12-12
申请人： 아이알엠 엘엘씨
发明人： 리우,홍 , 헤,시아오후이 , 필립스,딘 , 주,쉬에펭 , 양,군용 , 라우,토마스 , 우,바오젠 , 셰,융핑 , 엔구엔,트룩응옥 , 왕,씽
IPC分类号： C07D207/26 , C07D263/18 , A61K31/4015 , A61P25/00
CPC分类号： C07D265/32 , C07D207/26 , C07D207/40 , C07D233/12 , C07D233/16 , C07D233/32 , C07D233/38 , C07D233/42 , C07D233/46 , C07D233/50 , C07D233/52 , C07D233/74 , C07D263/20 , C07D263/22 , C07D285/06 , C07D403/04 , C07D403/06 , C07D403/14 , C07D413/04 , C07D413/06 , C07D413/12 , C07D413/14 , C07F7/1856
摘要： 본 발명은 칸나비노이드 수용체 1 (CB1)의 활성과 관련된 질환 또는 장애를 치료 또는 예방하기 위한 화합물, 상기 화합물을 포함하는 제약 조성물, 및 상기 화합물을 사용하여 상기 질환 또는 장애를 치료 또는 예방하는 방법을 제공한다.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式